The incidence of cellulitis is highly seasonal, and this seasonality may be explained by changes in the weather, specifically, temperature. At population level, admissions to the hospital for cellulitis risk are strongly associated with warmer weather.
Antiretroviral drugs less likely to induce steatosis progression are needed. In this clinical trial, we found that switching efavirenz by raltegravir was associated with decreases in steatosis among HIV-infected patients with nonalcoholic fatty liver disease.
